🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase IV, open-label, non-randomized study to demonstrate superio...
Status
Recruiting
Location
Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University
Start Date
2025-05-13
Trial ID
NCT06803524
Treatments Being Tested
The main objective is to determine whether immune responses to Tdap (GlaxoS...
Status
Completed
Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615
Start Date
2011-09
Trial ID
NCT01424644
The current study will provide information for the use of Boostrix concomit...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-23
Trial ID
NCT00385255
The overall objective of the project is to identify the determinants of ant...
Status
Completed
Location
CHU Saint-Pierre
Start Date
2023-09-12
Trial ID
NCT05856396
Treatments Being Tested
The purpose of this study is to evaluate the persistence of immune response...
Status
Completed
Location
Site 02, Center for Vaccinology (CEVAC), Ghent University Hospital
Start Date
2015-04
Trial ID
NCT02382913
Treatments Being Tested
New immunization recommendations in the US include vaccination of adolescen...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-25
Trial ID
NCT00282295
Primary Objective: * To demonstrate that ProQuad® can be administered conc...
Status
Completed
Location
Multiple Locations
Start Date
2007-01-12
Trial ID
NCT00432042
Treatments Being Tested
Despite good vaccination coverage, included in national immunization progra...
Status
Completed
Location
Centre for the Evaluation of Vaccination
Start Date
2012-02
Trial ID
NCT01698346
Treatments Being Tested
This study will determine whether participants who receive V419 (PR5I) at 2...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-23
Trial ID
NCT01480258
Treatments Being Tested